KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $1.9 billion.

  • Charles River Laboratories International's Retained Earnings fell 840.94% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 840.94%. This contributed to the annual value of $1.8 billion for FY2024, which is 398.04% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Retained Earnings of $1.9 billion as of Q3 2025, which was down 840.94% from $1.9 billion recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Retained Earnings registered a high of $2.1 billion during Q3 2024, and its lowest value of $686.9 million during Q1 2021.
  • Moreover, its 5-year median value for Retained Earnings was $1.6 billion (2023), whereas its average is $1.5 billion.
  • As far as peak fluctuations go, Charles River Laboratories International's Retained Earnings surged by 10747.45% in 2021, and later plummeted by 840.94% in 2025.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Retained Earnings stood at $980.8 million in 2021, then surged by 46.1% to $1.4 billion in 2022, then soared by 31.71% to $1.9 billion in 2023, then fell by 3.98% to $1.8 billion in 2024, then rose by 7.3% to $1.9 billion in 2025.
  • Its last three reported values are $1.9 billion in Q3 2025, $1.9 billion for Q2 2025, and $1.8 billion during Q1 2025.